NSEUpdates27 Jul 2026 · 27 Jul 2026, 04:44 pm

Updates

Bliss GVS Pharma Limited · BLISSGVS

✦ AI SummaryRegulatory

SBI Capital Markets Ltd has submitted a pre-offer advertisement and corrigendum to the detailed public statement for the attention of public shareholders of Bliss GVS Pharma Limited.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

SBI Capital Markets Ltd  has submitted to  the Exchange a copy of pre-offer advertisement in accordance with Regulation 18(7) of the SEBI (SAST) Regulations, 2011, as amended, and corrigendum to the detailed public statement for the attention  of the public shareholders of the company.